Serological Markers to Differentiate Between Ulcerative Colitis and Crohn's Disease

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1995 Apr 1

PMID 7615855

Citations 1

Authors

M Oudkerk Pool

G Bouma

S G Meuwissen

B M von Blomberg

J P van de Merwe

W L Deville

J C Fonk

A S Pena

Affiliations

Soon will be listed here.

Abstract

Aim: To assess prospectively the value of three serological tests for differentiating between ulcerative colitis and Crohn's disease, used either alone or combined.

Methods: Coded serum samples from 63 patients with ulcerative colitis and 67 patients with Crohn's disease were analysed. Detection assays for the presence of perinuclear antineutrophil cytoplasmic antibodies (pANCA), serum agglutinating antibodies to anaerobic coccoid rods, and specific IgG antibodies against a Kd-45/48 immunological crossreactive mycobacterial antigen complex (ImCrAC) were studied. Sensitivity, specificity, pre- and post-test probabilities, likelihood ratios, and predictive values of each of these serological tests were determined.

Results: The sensitivity and specificity of the pANCA test for the diagnosis of ulcerative colitis were 61 and 79%, respectively. The serum agglutination test for anaerobic coccoid rods had a sensitivity of 42% and a specificity of 89% for a diagnosis of Crohn's disease. The sensitivity of specific IgG antibodies against Kd-45/48 ImCrAC in diagnosing Crohn's disease was 70% and specificity 60%. Although 100% specificity was achieved by combining all three tests in a small group of patients with Crohn's disease (n = 20), combining two or more tests had no additive clinical value. No correlation was found between the presence of any one of these antibodies and disease activity, duration, or localisation of disease. Surgery or medical treatment did not influence the presence of antibodies or the antibody titre.

Conclusions: The value of these tests in the differential diagnosis between ulcerative colitis and Crohn's disease is limited, but the high predictive values and specificities of different tests for both diseases suggest that these tests may be of help in studying disease heterogeneity and in defining different subgroups of patients with different pathogenesis.

Citing Articles

Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.

Buckland M, Mylonaki M, Rampton D, Longhurst H Clin Diagn Lab Immunol. 2005; 12(11):1328-30.

PMID: 16275949 PMC: 1287772. DOI: 10.1128/CDLI.12.11.1328-1330.2005.

References

Howells B, Matthews N, Mayberry J, Rhodes J . Agglutinins to anaerobic bacteria in Crohn's disease and in Indian patients with diarrhoea. J Med Microbiol. 1984; 17(2):207-9. DOI: 10.1099/00222615-17-2-207. View

WENSINCK F, van de Merwe J . Serum agglutinins to Eubacterium and Peptostreptococcus species in Crohn's and other diseases. J Hyg (Lond). 1981; 87(1):13-24. PMC: 2134081. DOI: 10.1017/s0022172400069199. View

Sutherland L, Martin F, Greer S, Robinson M, Greenberger N, Saibil F . 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987; 92(6):1894-8. DOI: 10.1016/0016-5085(87)90621-4. View

Hazenberg M, van de Merwe J, Pena A, van Lieshout L . Antibodies to Coprococcus comes in sera of patients with Crohn's disease. Isolation and purification of the agglutinating antigen tested with an ELISA technique. J Clin Lab Immunol. 1987; 23(3):143-8. View

Wiik A . Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl. 1989; 6:12-3. View

Saxon A, Shanahan F, Landers C, Ganz T, Targan S . A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990; 86(2):202-10. DOI: 10.1016/s0091-6749(05)80067-3. View

Duerr R, Targan S, Landers C, Sutherland L, Shanahan F . Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology. 1991; 100(6):1590-6. DOI: 10.1016/0016-5085(91)90657-7. View

Colombel J, Reumaux D, Duthilleul P, Noel L, Gower-Rousseau C, Paris J . Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol. 1992; 16(8-9):656-60. View

Oudkerk Pool M, Ellerbroek P, Ridwan B, Goldschmeding R, von Blomberg B, Pena A . Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and.... Gut. 1993; 34(1):46-50. PMC: 1374099. DOI: 10.1136/gut.34.1.46. View

10.

Toyoda H, Wang S, Yang H, Redford A, Magalong D, Tyan D . Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology. 1993; 104(3):741-8. DOI: 10.1016/0016-5085(93)91009-7. View

11.

Yang H, McElree C, Roth M, Shanahan F, Targan S, Rotter J . Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993; 34(4):517-24. PMC: 1374314. DOI: 10.1136/gut.34.4.517. View

12.

Yang H, Rotter J, Toyoda H, Landers C, Tyran D, McElree C . Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest. 1993; 92(2):1080-4. PMC: 294949. DOI: 10.1172/JCI116613. View

13.

Mandal A, Dasgupta A, Jeffers L, Squillante L, Hyder S, Reddy R . Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology. 1994; 106(1):185-92. DOI: 10.1016/s0016-5085(94)95271-x. View

14.

Mulder A, Broekroelofs J, Horst G, Limburg P, Nelis G, Kallenberg C . Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin Exp Immunol. 1994; 95(3):490-7. PMC: 1535094. DOI: 10.1111/j.1365-2249.1994.tb07024.x. View

15.

Ellerbroek P, Oudkerk Pool M, Ridwan B, Dolman K, von Blomberg B, von dem Borne A . Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol. 1994; 47(3):257-62. PMC: 501907. DOI: 10.1136/jcp.47.3.257. View

16.

BROBERGER O, Perlmann P . Autoantibodies in human ulcerative colitis. J Exp Med. 1959; 110:657-74. PMC: 2137024. DOI: 10.1084/jem.110.5.657. View

17.

Calabresi P, Edwards E, SCHILLING R . Fluorescent antiglobulin studies in leukopenic and related disorders. J Clin Invest. 1959; 38:2091-100. PMC: 441796. DOI: 10.1172/JCI103987. View

18.

Lewkonia R, McConnell R . Progress report. Familial inflammatory bowel disease--heredity or environment?. Gut. 1976; 17(3):235-43. PMC: 1411159. DOI: 10.1136/gut.17.3.235. View

19.

Das K, Dubin R, Nagai T . Isolation and characterization of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis. Proc Natl Acad Sci U S A. 1978; 75(9):4528-32. PMC: 336149. DOI: 10.1073/pnas.75.9.4528. View

20.

DAVIDSON I, Lloyd R, Whorwell P, Wright R . Antibodies to maize in patients with Crohn's disease, ulcerative colitis and coeliac disease. Clin Exp Immunol. 1979; 35(1):147-8. PMC: 1537589. View